Decision and Details
LY Corporation and LINEヘルスケア株式会社Absorption-type merger in which LY Corporation is the surviving company and LINEヘルスケア株式会社 is the disappearing company
LINEヘルスケア株式会社 is a wholly owned subsidiary of LY Corporation, and there are no minority shareholders. LY Corporation is expected to be able to perform its obligations after the absorption-type merger.
LY Corporation’s assets are expected to continue to substantially exceed its liabilities after the effective date, and no event that would impede the performance of its obligations is currently expected to occur
| Item | Details |
|---|---|
| Matter Covered | Absorption-type merger in which LY Corporation is the surviving company and LINEヘルスケア株式会社 is the disappearing company |
| Decision-Making Body | LY Corporation and LINEヘルスケア株式会社 |
| Decision Date | 1 July 2026 (date of execution of the absorption-type merger agreement) |
| Implementation Date | 1 September 2026 (scheduled effective date) |
| Period Covered | On or after 1 September 2026 |
| Amount | Merger consideration: none; LY Corporation’s stated capital and legal reserves: no increase; LY Corporation’s assets: ¥3,782,588 million; LY Corporation’s liabilities: ¥1,551,601 million; LINEヘルスケア株式会社’s assets: ¥356,793 thousand; LINEヘルスケア株式会社’s liabilities: ¥1,486,504 thousand |
| Quantity / scale | LINEヘルスケア株式会社 is a wholly owned subsidiary of LY Corporation, which holds all of its issued shares |
| Impact on Business Performance | LY Corporation’s assets are expected to continue to substantially exceed its liabilities after the effective date, and no event that would impede the performance of its obligations is currently expected to occur |
| Reason | LINEヘルスケア株式会社 is a wholly owned subsidiary of LY Corporation, and there are no minority shareholders. LY Corporation is expected to be able to perform its obligations after the absorption-type merger. |
| Governing Rule | Companies Act, Article 782, paragraph 1; Companies Act, Article 794, paragraph 1; Companies Act Enforcement Regulations, Article 182; Companies Act Enforcement Regulations, Article 191; Companies Act, Article 784, paragraph 1; Companies Act, Article 796, paragraph 2; Companies Act, Article 795, paragraph 1; Companies Act, Article 319, paragraph 1; Companies Accounting Regulations, Article 2, paragraph 3, item 36 |
| Future plans | The absorption-type merger is scheduled to take effect on 1 September 2026. If necessary, the effective date may be changed by agreement between the two companies. If a material change or other significant event occurs, the merger terms may be amended or the agreement may be terminated. |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company explains that it is appropriate not to issue merger consideration because LINEヘルスケア株式会社 is a wholly owned subsidiary of LY Corporation, which holds all of its issued shares. It also states that LY Corporation’s assets are expected to continue to substantially exceed its liabilities after the effective date, and that no event is currently expected to impede the performance of its obligations.